• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
On the fitting of binding data when receptor dimerization is suspected.当怀疑存在受体二聚化时结合数据的拟合
Br J Pharmacol. 2008 Sep;155(1):17-23. doi: 10.1038/bjp.2008.234. Epub 2008 Jun 9.
2
Modeling cooperativity effects in dimeric G protein-coupled receptors.二聚体 G 蛋白偶联受体协同作用的建模。
Prog Mol Biol Transl Sci. 2013;115:349-73. doi: 10.1016/B978-0-12-394587-7.00008-7.
3
Modelling the interdependence between the stoichiometry of receptor oligomerization and ligand binding for a coexisting dimer/tetramer receptor system.模拟共存二聚体/四聚体受体系统中受体寡聚化化学计量与配体结合之间的相互依赖性。
Br J Pharmacol. 2009 Jan;156(1):28-35. doi: 10.1111/j.1476-5381.2008.00031.x.
4
Old and new ways to calculate the affinity of agonists and antagonists interacting with G-protein-coupled monomeric and dimeric receptors: the receptor-dimer cooperativity index.计算激动剂和拮抗剂与G蛋白偶联单体和二聚体受体相互作用亲和力的新旧方法:受体二聚体协同指数
Pharmacol Ther. 2007 Dec;116(3):343-54. doi: 10.1016/j.pharmthera.2007.05.010. Epub 2007 Jun 14.
5
Ligand Binding Dynamics for Pre-dimerised G Protein-Coupled Receptor Homodimers: Linear Models and Analytical Solutions.预二聚化 G 蛋白偶联受体同源二聚体的配体结合动力学:线性模型和解析解。
Bull Math Biol. 2019 Sep;81(9):3542-3574. doi: 10.1007/s11538-017-0387-x. Epub 2018 Jan 18.
6
The two-state dimer receptor model: a general model for receptor dimers.双态二聚体受体模型:受体二聚体的通用模型。
Mol Pharmacol. 2006 Jun;69(6):1905-12. doi: 10.1124/mol.105.020685. Epub 2006 Feb 24.
7
Reinterpreting anomalous competitive binding experiments within G protein-coupled receptor homodimers using a dimer receptor model.重新解释 G 蛋白偶联受体同源二聚体中异常竞争结合实验,使用二聚体受体模型。
Pharmacol Res. 2019 Jan;139:337-347. doi: 10.1016/j.phrs.2018.11.032. Epub 2018 Nov 22.
8
Mathematical modeling of G protein-coupled receptor function: what can we learn from empirical and mechanistic models?G 蛋白偶联受体功能的数学建模:从经验和机制模型中我们能学到什么?
Adv Exp Med Biol. 2014;796:159-81. doi: 10.1007/978-94-007-7423-0_8.
9
Negative cooperativity of glutamate binding in the dimeric metabotropic glutamate receptor subtype 1.二聚体代谢型谷氨酸受体亚型1中谷氨酸结合的负协同性。
J Biol Chem. 2004 Aug 20;279(34):35526-34. doi: 10.1074/jbc.M404831200. Epub 2004 Jun 15.
10
Evaluation of affinity sensor response kinetics towards dimeric ligands linked with spacers of different rigidity: Immobilized recombinant granulocyte colony-stimulating factor based synthetic receptor binding with genetically engineered dimeric analyte derivatives.评估与不同刚性间隔物连接的二聚配体的亲和传感器响应动力学:基于固定化重组粒细胞集落刺激因子的合成受体与基因工程二聚分析物衍生物的结合。
Biosens Bioelectron. 2020 May 15;156:112112. doi: 10.1016/j.bios.2020.112112. Epub 2020 Feb 25.

引用本文的文献

1
Ligand Binding Dynamics for Pre-dimerised G Protein-Coupled Receptor Homodimers: Linear Models and Analytical Solutions.预二聚化 G 蛋白偶联受体同源二聚体的配体结合动力学:线性模型和解析解。
Bull Math Biol. 2019 Sep;81(9):3542-3574. doi: 10.1007/s11538-017-0387-x. Epub 2018 Jan 18.
2
An automated fitting procedure and software for dose-response curves with multiphasic features.一种用于具有多相特征的剂量反应曲线的自动拟合程序和软件。
Sci Rep. 2015 Oct 1;5:14701. doi: 10.1038/srep14701.
3
Divergent label-free cell phenotypic pharmacology of ligands at the overexpressed β₂-adrenergic receptors.过表达的β₂-肾上腺素能受体配体的不同无标记细胞表型药理学
Sci Rep. 2014 Jan 23;4:3828. doi: 10.1038/srep03828.
4
Label-free integrative pharmacology on-target of opioid ligands at the opioid receptor family.阿片受体家族中阿片配体的无标记综合药物靶点。
BMC Pharmacol Toxicol. 2013 Mar 12;14:17. doi: 10.1186/2050-6511-14-17.
5
Serotonin-glutamate and serotonin-dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic scaffolding and effector proteins.5-羟色胺-谷氨酸和 5-羟色胺-多巴胺的相互作用作为新型抗精神病治疗的潜在分子靶点:从受体异二聚体到突触后支架和效应蛋白。
Psychopharmacology (Berl). 2013 Jan;225(1):1-19. doi: 10.1007/s00213-012-2921-8. Epub 2012 Nov 21.
6
Reflections on the theory of "silver bullet" octreotide tracers: implications for ligand-receptor interactions in the age of peptides, heterodimers, receptor mosaics, truncated receptors, and multifractal analysis.关于“银弹”奥曲肽示踪剂理论的思考:肽、异二聚体、受体嵌合体、截断受体和多重分形分析时代配体-受体相互作用的启示。
EJNMMI Res. 2011 Jul 26;1(1):9. doi: 10.1186/2191-219X-1-9.
7
Biased signalling and allosteric machines: new vistas and challenges for drug discovery.偏向信号和别构机器:药物发现的新视野和新挑战。
Br J Pharmacol. 2012 Mar;165(6):1659-1669. doi: 10.1111/j.1476-5381.2011.01749.x.
8
Ligand-directed functional selectivity at the mu opioid receptor revealed by label-free integrative pharmacology on-target.基于靶点的无标记整合药理学揭示μ阿片受体配体导向的功能选择性
PLoS One. 2011;6(10):e25643. doi: 10.1371/journal.pone.0025643. Epub 2011 Oct 7.
9
Functional crosstalk and heteromerization of serotonin 5-HT2A and dopamine D2 receptors.5-羟色胺 5-HT2A 受体和多巴胺 D2 受体的功能串扰和异源二聚化。
Neuropharmacology. 2011 Sep;61(4):770-7. doi: 10.1016/j.neuropharm.2011.05.023. Epub 2011 May 27.
10
Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists.代谢型谷氨酸 mGlu2 受体是致幻 5-HT2A 受体激动剂引起的药理学和行为学效应所必需的。
Neurosci Lett. 2011 Apr 15;493(3):76-9. doi: 10.1016/j.neulet.2011.01.046. Epub 2011 Jan 27.

本文引用的文献

1
How and why do GPCRs dimerize?G蛋白偶联受体(GPCRs)如何以及为何会二聚化?
Trends Pharmacol Sci. 2008 May;29(5):234-40. doi: 10.1016/j.tips.2008.02.004. Epub 2008 Apr 1.
2
Dimerization and oligomerization of G-protein-coupled receptors: debated structures with established and emerging functions.G蛋白偶联受体的二聚化和寡聚化:结构存在争议但功能已明确且不断涌现新功能
J Endocrinol. 2008 Mar;196(3):435-53. doi: 10.1677/JOE-07-0573.
3
Identification of a serotonin/glutamate receptor complex implicated in psychosis.与精神病相关的5-羟色胺/谷氨酸受体复合物的鉴定。
Nature. 2008 Mar 6;452(7183):93-7. doi: 10.1038/nature06612. Epub 2008 Feb 24.
4
Modeling the binding and function of metabotropic glutamate receptors.模拟代谢型谷氨酸受体的结合与功能。
J Pharmacol Exp Ther. 2008 May;325(2):443-56. doi: 10.1124/jpet.107.133967. Epub 2008 Feb 20.
5
Conformational cross-talk between alpha2A-adrenergic and mu-opioid receptors controls cell signaling.α2A-肾上腺素能受体与μ-阿片受体之间的构象串扰控制细胞信号传导。
Nat Chem Biol. 2008 Feb;4(2):126-31. doi: 10.1038/nchembio.64. Epub 2008 Jan 13.
6
G-protein-coupled receptor heteromers: function and ligand pharmacology.G蛋白偶联受体异聚体:功能与配体药理学
Br J Pharmacol. 2008 Mar;153 Suppl 1(Suppl 1):S90-8. doi: 10.1038/sj.bjp.0707571. Epub 2007 Nov 26.
7
Why the Schild method is better than Schild realised.为什么希尔氏方法比希尔所意识到的更好。
Trends Pharmacol Sci. 2007 Dec;28(12):608-14. doi: 10.1016/j.tips.2007.09.011. Epub 2007 Nov 26.
8
A day in the life of a G protein-coupled receptor: the contribution to function of G protein-coupled receptor dimerization.G蛋白偶联受体的一天:G蛋白偶联受体二聚化对其功能的贡献
Br J Pharmacol. 2008 Mar;153 Suppl 1(Suppl 1):S216-29. doi: 10.1038/sj.bjp.0707490. Epub 2007 Oct 29.
9
Old and new ways to calculate the affinity of agonists and antagonists interacting with G-protein-coupled monomeric and dimeric receptors: the receptor-dimer cooperativity index.计算激动剂和拮抗剂与G蛋白偶联单体和二聚体受体相互作用亲和力的新旧方法:受体二聚体协同指数
Pharmacol Ther. 2007 Dec;116(3):343-54. doi: 10.1016/j.pharmthera.2007.05.010. Epub 2007 Jun 14.
10
Allosteric properties of G protein-coupled receptor oligomers.G蛋白偶联受体寡聚体的变构特性。
Pharmacol Ther. 2007 Sep;115(3):410-8. doi: 10.1016/j.pharmthera.2007.06.004. Epub 2007 Jun 27.

当怀疑存在受体二聚化时结合数据的拟合

On the fitting of binding data when receptor dimerization is suspected.

作者信息

Giraldo J

机构信息

Grup Biomatemàtic de Recerca, Institut de Neurociències and Unitat de Bioestadística, Universitat Autònoma de Barcelona, Bellaterra, Spain.

出版信息

Br J Pharmacol. 2008 Sep;155(1):17-23. doi: 10.1038/bjp.2008.234. Epub 2008 Jun 9.

DOI:10.1038/bjp.2008.234
PMID:18536745
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2527846/
Abstract

Mechanistic and empirical modelling are compared in context of dimeric receptors. In particular, the supposed advantages of the two-state dimer model for fitting of binding data with respect to classical approaches such as the two-independent sites model are investigated. The two models are revisited from both the mechanistic and empirical point of views. The problem of overparameterized models and the benefits of the concurrent use of mechanistic and empirical models for mechanism analysis are discussed. The pros and cons of mathematical models are examined with special emphasis given to the interpretation of the connection between the shapes of the curves and receptor cooperativity. It is shown that a given pharmacological phenotype (curve shape) can be obtained from different receptor genotypes (as, for instance, non-interconvertible monomeric receptor species, receptor-G protein interactions and dimeric receptors), though values of the Hill coefficient greater than one are indicative of receptor oligomerization. The existence of a relationship between the recently defined dimer cooperativity index and the more familiar Hill coefficient is proven.

摘要

在二聚体受体的背景下对机理模型和经验模型进行了比较。特别地,研究了二态二聚体模型在拟合结合数据方面相对于诸如双独立位点模型等经典方法的假定优势。从机理和经验两个角度重新审视了这两种模型。讨论了模型参数过多的问题以及同时使用机理模型和经验模型进行机理分析的好处。特别强调了曲线形状与受体协同性之间联系的解释,对数学模型的优缺点进行了研究。结果表明,给定的药理学表型(曲线形状)可以从不同的受体基因型(例如,不可相互转化的单体受体种类、受体 - G蛋白相互作用和二聚体受体)获得,尽管希尔系数大于1的值表明受体寡聚化。证明了最近定义的二聚体协同性指数与更为人熟知的希尔系数之间存在关系。